Translating Clinical Trial Evidence to Routine Practice—How Do We Overcome the Barriers?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Translating Clinical Trial Evidence to Routine Practice—How Do We Overcome the Barriers?

Published:2022-05-01 Issue:5 Volume:8 Page:728
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Tang Monica¹²,Lee Chee Khoon²³

Affiliation:

1. Centre for Big Data Research in Health, University of New South Wales, UNSW Sydney, NSW, Australia

2. St George Hospital Cancer Care Centre, Kogarah, NSW, Australia

3. National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Camperdown, NSW, Australia

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2790375/jamaoncology_tang_2022_ic_220001_1652478737.79613.pdf

Reference7 articles.

1. Osimertinib in resected EGFR-mutated non–small-cell lung cancer.;Wu;N Engl J Med,2020

2. Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial.;Felip;Lancet,2021

3. Rates of guideline-concordant surgery and adjuvant chemotherapy among patients with early-stage lung cancer in the US ALCHEMIST study (Alliance A151216).;Kehl;JAMA Oncol

4. County-level variations in receipt of surgery for early-stage non-small cell lung cancer in the United States.;Sineshaw;Chest,2020

5. Quality measures in clinical stage I non-small cell lung cancer: improved performance is associated with improved survival.;Samson;Ann Thorac Surg,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Survival Impact of New Treatment Strategies for Lung Cancer: A 2000–2020 French Cohort;Cancers;2024-08-05

2. Unlocking the potential of Molecular Tumor Boards: from cutting-edge data interpretation to innovative clinical pathways;Critical Reviews in Oncology/Hematology;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3